This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.

Sandbox Reserved 1240

From Proteopedia

(Difference between revisions)

Jump to: navigation, search

Revision as of 20:03, 20 April 2017

This Sandbox is Reserved from Jan 17 through June 31, 2017 for use in the course Biochemistry II taught by Jason Telford at the Maryville University, St. Louis, USA. This reservation includes Sandbox Reserved 1225 through Sandbox Reserved 1244.

To get started:

Click the edit this page tab at the top. Save the page after each step, then edit it again.
Click the 3D button (when editing, above the wikitext box) to insert Jmol.
show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing

Structure

Overall, the structure of Glucose-6-Phosphate Dehydrogenase (G6PD) is a tetramer, composed of a dimer of dimers. Glucose-6-Phosphate Dehydrogenase also features a structural nicotinamide adenine, which is only present in eukaryotes and is rare biologically. Glucose-6-Phosphate Dehydrogenase is 515 amino acids long.

1 Function
2 Disease
3 Relevance
4 Structural highlights

Function

Glucose-6-Phosphate Dehydrogenase is the rate-limiting enzyme in the pentose phosphate pathway. GGPD converts Glucose-6-Phosphate into 6-phosphoglucono-δ-lactone. Dysfunction of G6PD has multiple down stream effects. The pentose phosphate pathway synthesizes precursors for multiple other biosynthetic pathways. For example, it synthesizes nucleotide precursors for DNA synthesis.

Disease

Glucose-6-Phosphate Dehydrogenase deficiency is associated with many diseases, some of which include Hemolytic Anemia and Favism. Hemolytic Anemia results in erythrocytes being destroyed before their typical life span is over. Hemolytic anemia can lead to many problems, including cardiovascular arrhythmia, cardiomegaly (enlarged heart), and fatigue. Hemolytic anemia can present with different severity, but can be treated with drugs.

Favism is a disease associated with G6PD deficiency that can cause oxidative stress as a result of consuming fava beans. Favism and G6PD are X-linked diseases that are thus more prevalent in men than women.

Relevance

Glucose-6-Phosphate Dehydrogenase plays a key role in maintaining homeostasis. Not only does it catalyze the rate limiting step of the oxidative pentose phosphate pathway, it maintains the shape of red blood cells by protecting against potential deadly reactive oxygen species. Glucose-6-Phosphate dehydrogenase deficiency is the most common enzyme deficiency in humans, affecting over 400 million people worldwide. G6PD deficiency resulted in 4100 deaths worldwide in 2013.

Structural highlights

The two dimers are held together in a tetramer by charge-charge interactions.

References

Au, Shannon et al. "Human Glucose-6-Phosphate Dehydrogenase: The Crystal Structure Reveals A Structural NADP+ Molecule And Provides Insights Into Enzyme

    Deficiency". N.p., 2017. Web. 20 Apr. 2017.

Berg, Jeremy, John Tymoczko, and Lubert Stryer. "Glucose 6-Phosphate Dehydrogenase Plays A Key Role In Protection Against Reactive Oxygen Species".

    Ncbi.nlm.nih.gov. N.p., 2017. Web. 20 Apr. 2017.

"G6PD Gene - Genecards | G6PD Protein | G6PD Antibody". Genecards.org. N.p., 2017. Web. 20 Apr. 2017. "Glucose-6-Phosphate Dehydrogenase". Wikipedia.org. N.p., 2017. Web. 20 Apr. 2017. "What Is Hemolytic Anemia? - NHLBI, NIH". Nhlbi.nih.gov. N.p., 2017. Web. 20 Apr. 2017.

Retrieved from "http://52.214.119.220/wiki/index.php/Sandbox_Reserved_1240"

Sandbox Reserved 1240

From Proteopedia

Revision as of 20:03, 20 April 2017

Structure

Contents

Function

Disease

Relevance

Structural highlights

References

Views

Personal tools

Navigation

Search

Toolbox

@@ Line 20: / Line 20: @@
 == <b>References</b> ==
 <references/>
+Au, Shannon et al. "Human Glucose-6-Phosphate Dehydrogenase: The Crystal Structure Reveals A Structural NADP+ Molecule And Provides Insights Into Enzyme
-Au, Shannon et al. "Human Glucose-6-Phosphate Dehydrogenase: The Crystal Structure Reveals A Structural NADP+ Molecule And Provides Insights Into Enzyme Deficiency". N.p., 2017. Web. 20 Apr. 2017.
+     Deficiency". N.p., 2017. Web. 20 Apr. 2017.
+Berg, Jeremy, John Tymoczko, and Lubert Stryer. "Glucose 6-Phosphate Dehydrogenase Plays A Key Role In Protection Against Reactive Oxygen Species".
-Berg, Jeremy, John Tymoczko, and Lubert Stryer. "Glucose 6-Phosphate Dehydrogenase Plays A Key Role In Protection Against Reactive Oxygen Species". Ncbi.nlm.nih.gov. N.p., 2017. Web. 20 Apr. 2017.
+     Ncbi.nlm.nih.gov. N.p., 2017. Web. 20 Apr. 2017.
 "G6PD Gene - Genecards | G6PD Protein | G6PD Antibody". Genecards.org. N.p., 2017. Web. 20 Apr. 2017.
 "Glucose-6-Phosphate Dehydrogenase". Wikipedia.org. N.p., 2017. Web. 20 Apr. 2017.
 "What Is Hemolytic Anemia? - NHLBI, NIH". Nhlbi.nih.gov. N.p., 2017. Web. 20 Apr. 2017.